TSE:CMED - CanniMed Therapeutics Stock Price, Price Target & More

C$32.52 -1.02 (-3.04 %)
(As of 04/19/2018 11:55 AM ET)
Previous CloseC$33.54
Today's RangeC$32.50 - C$33.71
52-Week RangeC$7.32 - C$46.00
Volume13,168 shs
Average Volume424,047 shs
Market CapitalizationC$954.12 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About CanniMed Therapeutics (TSE:CMED)

CanniMed Therapeutics Inc. operates as a plant biopharmaceutical company that specializes in medical cannabis. The company cultivates and sells pharmaceutical-grade cannabis products in dried herbal and oil forms for Canadian patients. It also offers herbal cannabis and cannabis oil; and vaporizers, consumable vaporizer accessories, and herb mills. In addition, the company offers a plant biotechnology research and product development program that focuses on the production of plant-based materials for pharmaceutical, agricultural, and environmental applications. CanniMed Therapeutics Inc. was founded in 1988 and is based in Saskatoon, Canada.

Receive CMED News and Ratings via Email

Sign-up to receive the latest news and ratings for CMED and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryCannabis
SectorN/A
SymbolTSE:CMED
CUSIPN/A
Phone+1-306-9751207

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-28.43%
Return on Equity-5.96%
Return on Assets-4.95%

Miscellaneous

EmployeesN/A
Outstanding Shares24,757,000

How to Become a New Pot Stock Millionaire

CanniMed Therapeutics (TSE:CMED) Frequently Asked Questions

What is CanniMed Therapeutics' stock symbol?

CanniMed Therapeutics trades on the Toronto Stock Exchange (TSX) under the ticker symbol "CMED."

Who are some of CanniMed Therapeutics' key competitors?

Who are CanniMed Therapeutics' key executives?

CanniMed Therapeutics' management team includes the folowing people:
  • Donald R. Ching, Independent Chairman of the Board (Age 74)
  • Brent Zettl, President, Chief Executive Officer, Director (Age 54)
  • John L. Knowles, Chief Financial Officer, Corporate Secretary, Director (Age 61)
  • Gulwant Bajwa, Vice President - Business Development and Regulatory Affairs (Age 54)
  • Larry Holbrook, Chief Research Officer (Age 69)
  • Douglas W. Banzet, Independent Director (Age 66)
  • Rob Duguid, Independent Director (Age 52)
  • Marianne Greer Ph.D., Independent Director (Age 63)
  • Richard Hoyt, Independent Director (Age 63)
  • Dwayne Lawrence Lashyn, Independent Director (Age 52)

Has CanniMed Therapeutics been receiving favorable news coverage?

Media stories about CMED stock have trended somewhat negative recently, according to Accern Sentiment Analysis. The research firm scores the sentiment of press coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. CanniMed Therapeutics earned a media sentiment score of -0.03 on Accern's scale. They also gave news articles about the company an impact score of 46.31 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next several days.

How do I buy shares of CanniMed Therapeutics?

Shares of CMED and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is CanniMed Therapeutics' stock price today?

One share of CMED stock can currently be purchased for approximately C$32.52.

How big of a company is CanniMed Therapeutics?

CanniMed Therapeutics has a market capitalization of C$954.12 million.

How can I contact CanniMed Therapeutics?

CanniMed Therapeutics' mailing address is 1 Plant Technology Road, Box 19A, RR #5, SASKATOON, SK S7K 3J8, Canada. The company can be reached via phone at +1-306-9751207.


MarketBeat Community Rating for CanniMed Therapeutics (CMED)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  99 (Vote Outperform)
Underperform Votes:  57 (Vote Underperform)
Total Votes:  156
MarketBeat's community ratings are surveys of what our community members think about CanniMed Therapeutics and other stocks. Vote "Outperform" if you believe CMED will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CMED will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

CanniMed Therapeutics (TSE:CMED) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
(Data available from 4/19/2016 forward)

Earnings

Dividends

CanniMed Therapeutics (TSE:CMED) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

CanniMed Therapeutics (TSE CMED) Insider Trading and Institutional Ownership History

Insider Trading History for CanniMed Therapeutics (TSE:CMED)

CanniMed Therapeutics (TSE CMED) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/8/2018Allan Mclay FowlerInsiderSell31,777C$31.81C$1,010,826.37
1/31/2018Larry HolbrookInsiderSell10,000C$34.89C$348,900.00
10/3/2017Larry HolbrookInsiderSell5,000C$10.25C$51,250.00
9/18/2017Larry HolbrookInsiderSell1,000C$9.41C$9,410.00
7/31/2017Larry HolbrookInsiderSell100C$10.05C$1,005.00
7/13/2017Saskworks Venture Fund Inc.InsiderBuy126,500C$8.35C$1,056,275.00
7/7/2017Saskworks Venture Fund Inc.InsiderBuy21,500C$8.14C$175,010.00
6/28/2017Brenton Harold ZettlDirectorBuy7,300C$7.99C$58,327.00
6/27/2017Brenton Harold ZettlDirectorBuy7,300C$7.99C$58,327.00
6/15/2017Brenton Harold ZettlDirectorBuy50,000C$7.91C$395,500.00
(Data available from 1/1/2013 forward)

Headlines

CanniMed Therapeutics (TSE CMED) News Headlines

Source:
DateHeadline
Who Are The Top Investors In CanniMed Therapeutics Inc (TSE:CMED)?Who Are The Top Investors In CanniMed Therapeutics Inc (TSE:CMED)?
finance.yahoo.com - April 18 at 5:43 PM
Why CanniMed Therapeutics Inc’s (TSE:CMED) ROE Of 3.37% Does Not Tell The Whole StoryWhy CanniMed Therapeutics Inc’s (TSE:CMED) ROE Of 3.37% Does Not Tell The Whole Story
finance.yahoo.com - April 10 at 5:28 PM
UPDATE 1-CanniMed CEO resigns, Aurora Therapeutics exec tapped interim CEOUPDATE 1-CanniMed CEO resigns, Aurora Therapeutics exec tapped interim CEO
www.reuters.com - April 2 at 8:43 AM
CanniMed CEO resigns, Aurora Therapeutics exec tapped interim CEOCanniMed CEO resigns, Aurora Therapeutics exec tapped interim CEO
finance.yahoo.com - April 2 at 8:43 AM
Is Aphria Inc. Still Harbouring U.S. Expansion Ambitions?Is Aphria Inc. Still Harbouring U.S. Expansion Ambitions?
www.fool.ca - March 26 at 5:14 PM
Today’s Research Reports on Knight Therapeutics, Crescita Therapeutics, CanniMed Therapeutics and Cipher PharmaceuticalsToday’s Research Reports on Knight Therapeutics, Crescita Therapeutics, CanniMed Therapeutics and Cipher Pharmaceuticals
finance.yahoo.com - March 22 at 8:30 AM
CanniMed Therapeutics Inc. Announces First Quarter ResultsCanniMed Therapeutics Inc. Announces First Quarter Results
finance.yahoo.com - March 19 at 8:25 AM
Changes to CanniMed Therapeutics Board Following Share Take ... - Business Wire (press release)Changes to CanniMed Therapeutics Board Following Share Take ... - Business Wire (press release)
www.businesswire.com - March 17 at 8:30 AM
Is CanniMed Therapeutics Inc’s (TSE:CMED) Balance Sheet A Threat To Its Future?Is CanniMed Therapeutics Inc’s (TSE:CMED) Balance Sheet A Threat To Its Future?
finance.yahoo.com - March 17 at 8:30 AM
Pot producer Aurora wins shareholder support for CanniMed purchase - ReutersPot producer Aurora wins shareholder support for CanniMed purchase - Reuters
www.reuters.com - March 10 at 8:25 AM
Pot producer Aurora wins shareholder support for CanniMed purchasePot producer Aurora wins shareholder support for CanniMed purchase
finance.yahoo.com - March 9 at 6:47 PM
Aurora Cannabis Announces Success in Bid for CanniMed Therapeutics Through the Take-Up of SharesAurora Cannabis Announces Success in Bid for CanniMed Therapeutics Through the Take-Up of Shares
finance.yahoo.com - March 9 at 6:47 PM
Aurora Cannabis Shareholders Give the Company the Okay to Acquire CanniMed TherapeuticsAurora Cannabis Shareholders Give the Company the Okay to Acquire CanniMed Therapeutics
www.baystreet.ca - March 8 at 6:38 PM
Aurora Cannabis Announces Receipt of Final Regulatory Approval for CanniMed Therapeutics Acquisition and its Intention to Take-Up as soon as Minimum Tender Condition is MetAurora Cannabis Announces Receipt of Final Regulatory Approval for CanniMed Therapeutics Acquisition and its Intention to Take-Up as soon as Minimum Tender Condition is Met
finance.yahoo.com - February 28 at 6:02 PM
Pot producer Aurora gets final regulatory nod for CanniMed purchasePot producer Aurora gets final regulatory nod for CanniMed purchase
finance.yahoo.com - February 28 at 6:02 PM
CanniMed Medical Cannabis Topical Cream Provides Fast-Acting Relief to Patients in Need - Business Wire (press release)CanniMed Medical Cannabis Topical Cream Provides Fast-Acting Relief to Patients in Need - Business Wire (press release)
www.businesswire.com - February 28 at 8:20 AM
CanniMed Medical Cannabis Topical Cream Provides Fast-Acting Relief to Patients in NeedCanniMed Medical Cannabis Topical Cream Provides Fast-Acting Relief to Patients in Need
finance.yahoo.com - February 28 at 8:20 AM
UPDATE--CTT Pharmaceutical Holdings, Inc., (CTTH) Announces Canadian Patent for Orally Administrable Nanonized ... - NasdaqUPDATE--CTT Pharmaceutical Holdings, Inc., (CTTH) Announces Canadian Patent for Orally Administrable Nanonized ... - Nasdaq
www.nasdaq.com - February 22 at 8:24 AM
Allan Mclay Fowler Sells 31,777 Shares of CanniMed Therapeutics Inc (CMED) StockAllan Mclay Fowler Sells 31,777 Shares of CanniMed Therapeutics Inc (CMED) Stock
www.americanbankingnews.com - February 12 at 9:16 PM
Marijuana Stocks: A Performance Review and a Look AheadMarijuana Stocks: A Performance Review and a Look Ahead
www.fool.ca - February 12 at 9:51 AM
Aurora Cannabis Inc. vs. Canopy Growth Corp.: Which Heavyweight Cannabis Stock Is the Best Bet Going Forward?Aurora Cannabis Inc. vs. Canopy Growth Corp.: Which Heavyweight Cannabis Stock Is the Best Bet Going Forward?
www.fool.ca - February 3 at 9:41 AM
Larry Holbrook Sells 10,000 Shares of CanniMed Therapeutics Inc (CMED) StockLarry Holbrook Sells 10,000 Shares of CanniMed Therapeutics Inc (CMED) Stock
www.americanbankingnews.com - February 1 at 6:30 PM
What Scotts Miracle-Gro Said about Its Cannabis-Focused BusinessWhat Scotts Miracle-Gro Said about Its Cannabis-Focused Business
finance.yahoo.com - January 31 at 9:56 AM
CanniMed Therapeutics Inc. Announces 2017 Year End Financials Release DateCanniMed Therapeutics Inc. Announces 2017 Year End Financials Release Date
finance.yahoo.com - January 27 at 9:40 AM
Aurora Cannabis Inc. vs. CanniMed Therapeutics Inc.: I’m Not SurprisedAurora Cannabis Inc. vs. CanniMed Therapeutics Inc.: I’m Not Surprised
www.fool.ca - January 25 at 3:45 PM
Canadas Aurora Cannabis to buy CanniMed for C$1.1 billionCanada's Aurora Cannabis to buy CanniMed for C$1.1 billion
www.reuters.com - January 25 at 3:45 PM
PRESS DIGEST- Canada-Jan 25PRESS DIGEST- Canada-Jan 25
finance.yahoo.com - January 25 at 9:46 AM
CanniMed Therapeutics Announces Continued Discussions with Aurora - Business Wire (press release)CanniMed Therapeutics Announces Continued Discussions with Aurora - Business Wire (press release)
www.businesswire.com - January 24 at 8:08 AM
PRESS DIGEST- Canada - Jan 24PRESS DIGEST- Canada - Jan 24
finance.yahoo.com - January 24 at 8:08 AM
PRESS DIGEST- Canada-Jan 23PRESS DIGEST- Canada-Jan 23
finance.yahoo.com - January 23 at 5:24 PM
CanniMed Therapeutics Announces Continued Discussions with AuroraCanniMed Therapeutics Announces Continued Discussions with Aurora
finance.yahoo.com - January 23 at 5:24 PM
CanniMed Therapeutics Announces Continuation of Discussions with AuroraCanniMed Therapeutics Announces Continuation of Discussions with Aurora
finance.yahoo.com - January 22 at 3:56 PM
CANADA STOCKS-TSX retreats as railroad and materials shares weighCANADA STOCKS-TSX retreats as railroad and materials shares weigh
finance.yahoo.com - January 22 at 3:56 PM
Canadian cannabis firm Aurora in talks to buy both CanniMed and Newstrike: sourcesCanadian cannabis firm Aurora in talks to buy both CanniMed and Newstrike: sources
www.reuters.com - January 19 at 6:28 PM
CanniMed Topical Cream – An Innovative New Way to Help Patients - Business Wire (press release)CanniMed Topical Cream – An Innovative New Way to Help Patients - Business Wire (press release)
www.businesswire.com - January 18 at 9:17 AM
CanniMed Therapeutics Reminds Shareholders to Vote the GREEN Proxy FOR the Acquisition of Newstrike Resources - Business Wire (press release)CanniMed Therapeutics Reminds Shareholders to Vote the GREEN Proxy FOR the Acquisition of Newstrike Resources - Business Wire (press release)
www.businesswire.com - January 18 at 9:17 AM
Up Cannabis-parent Newstrikes shareholders approve sale to CanniMedUp Cannabis-parent Newstrike's shareholders approve sale to CanniMed
finance.yahoo.com - January 17 at 5:58 PM
CanniMed Therapeutics Inc. Announces Director ResignationCanniMed Therapeutics Inc. Announces Director Resignation
finance.yahoo.com - January 17 at 8:44 AM
CanniMed Topical Cream – An Innovative New Way to Help PatientsCanniMed Topical Cream – An Innovative New Way to Help Patients
finance.yahoo.com - January 17 at 8:44 AM
CanniMed Therapeutics Reminds Shareholders to Vote the GREEN Proxy FOR the Acquisition of Newstrike ResourcesCanniMed Therapeutics Reminds Shareholders to Vote the GREEN Proxy FOR the Acquisition of Newstrike Resources
finance.yahoo.com - January 17 at 8:44 AM
Shareholders of Aurora Cannabis Inc. Will Get Some Important Answers This WeekShareholders of Aurora Cannabis Inc. Will Get Some Important Answers This Week
www.fool.ca - January 15 at 5:46 PM
CanniMed Therapeutics Inc. Launches $725 Million Lawsuit Alleging Multiple Claims of Wrongdoing Related to Aurora Hostile BidCanniMed Therapeutics Inc. Launches $725 Million Lawsuit Alleging Multiple Claims of Wrongdoing Related to Aurora Hostile Bid
www.businesswire.com - January 13 at 9:00 AM
Leading Independent Proxy Advisor ISS Recommends CanniMed Shareholders Vote “FOR” the Newstrike AcquisitionLeading Independent Proxy Advisor ISS Recommends CanniMed Shareholders Vote “FOR” the Newstrike Acquisition
finance.yahoo.com - January 11 at 5:55 PM
CanniMed Therapeutics Inc. and Up Cannabis Inc. (Wholly-Owned Licensed Producer of Newstrike Resources Ltd.) Applaud the Province of Saskatchewan on Legalization FrameworkCanniMed Therapeutics Inc. and Up Cannabis Inc. (Wholly-Owned Licensed Producer of Newstrike Resources Ltd.) Applaud the Province of Saskatchewan on Legalization Framework
finance.yahoo.com - January 8 at 5:57 PM
CanniMed Therapeutics Inc. and Up Cannabis Inc. (Wholly-Owned Licensed Producer of Newstrike Resources Ltd ... - Business Wire (press release)CanniMed Therapeutics Inc. and Up Cannabis Inc. (Wholly-Owned Licensed Producer of Newstrike Resources Ltd ... - Business Wire (press release)
www.businesswire.com - January 3 at 8:12 AM
Canadian regulators ask CanniMed to abandon rights plan against Aurora bid - ReutersCanadian regulators ask CanniMed to abandon rights plan against Aurora bid - Reuters
www.reuters.com - December 28 at 5:13 PM
Aurora Cannabis opposes CanniMeds bid for Newstrike Resources - ReutersAurora Cannabis opposes CanniMed's bid for Newstrike Resources - Reuters
www.reuters.com - December 19 at 5:46 PM
CanniMed Therapeutics Inc.s Latest Attempt to Stifle the Aurora Cannabis Inc. Takeover Bid - The Motley Fool CanadaCanniMed Therapeutics Inc.'s Latest Attempt to Stifle the Aurora Cannabis Inc. Takeover Bid - The Motley Fool Canada
www.fool.ca - December 19 at 5:46 PM
Ontario regulator to hear Aurora, CanniMed cases on Dec. 20Ontario regulator to hear Aurora, CanniMed cases on Dec. 20
finance.yahoo.com - December 13 at 5:59 PM
Aurora Cannabis wins rights for licensing talks with CannaRoyaltyAurora Cannabis wins rights for licensing talks with CannaRoyalty
finance.yahoo.com - December 13 at 9:14 AM

SEC Filings

CanniMed Therapeutics (TSE:CMED) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

CanniMed Therapeutics (TSE CMED) Stock Chart for Thursday, April, 19, 2018

Loading chart…

This page was last updated on 4/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.